Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 +0.99 (+0.95%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Exact Sciences: Q2 Earnings Insights ↗

July 28, 2021

Shares of Exact Sciences (NASDAQ:EXAS) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 77.59% over the...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Why Exact Sciences Is Trading Higher Today ↗

May 20, 2021

Exact Sciences Corp (NASDAQ:EXAS) is trading higher Thursd...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Unusual Options Activity Insight: Exact Sciences ↗

July 14, 2021

Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Wednesday. The stock price moved down to $112.83 following the option alert. Sentiment: BULLISH...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

Cramer Gives His Opinion On Novavax, Exact Sciences And More ↗

June 08, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Moderna Inc (NASDAQ: MRNA) over Novavax, Inc. (NASDAQ: NVAX). Philip Morris International Inc. (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 ↗

June 03, 2021

Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Why Exact Sciences Stock Soared Today ↗

May 20, 2021

The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.

Via The Motley Fool

Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why ↗

May 20, 2021

Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection.

Via Investor's Business Daily

Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know ↗

May 16, 2021

Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...

Via Benzinga

Exact Sciences' First-Quarter Results Show Its Strength Under Pressure ↗

May 15, 2021

Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?

Via The Motley Fool

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗

May 14, 2021

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...

Via Benzinga

Why Exact Sciences Doesn't Have Much to Worry About With Declining COVID Testing ↗

May 13, 2021

The company has other more significant growth drivers.

Via The Motley Fool

3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗

May 13, 2021

Falling costs are ushering in a new era of screening for a dreaded disease.

Via The Motley Fool

Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...

Via Benzinga

ARKK Stocks Breakdowns and Bounces ↗

May 07, 2021

After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.

Via Talk Markets

Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip ↗

May 06, 2021

Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday. SKLZ shares closed 9% lower...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

May 05, 2021

Raymond James lifted the price target on CVS Health Corporation (NYSE: CVS) from $90 to $95. CVS Health shares rose 0.2% to $81.26 in pre-market trading. Morgan Stanley boosted...

Via Benzinga

Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy ↗

May 05, 2021

There was a big asterisk with the company's improved bottom line.

Via The Motley Fool

Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

EXAS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Cathie Wood Loaded Up Further On Skillz On Earnings Day ↗

May 05, 2021

Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $52.1 million, in Skillz Inc (NYSE: SKLZ) ahead of the mobile gaming company’s first-...

Via Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

2 Cathie Wood Picks That Can Become Bigger Winners Than Tesla ↗

April 22, 2021

Digital wallets and genomics will transform the world in coming years.

Via The Motley Fool

Topics Electric Vehicles

Cathie Wood Buys Peloton, Coinbase Dips, Cuts Nvidia Stake ↗

April 20, 2021

Cathie Wood-led Ark Investment Management on Monday snapped up shares of the exercise bike maker Peloton Interactive Inc (NASDAQ:

Via Benzinga

Cathie Wood Cuts Square Stake And Snaps Up More Coinbase On Day Two ↗

April 16, 2021

Cathie Wood-led Ark Investment Management on Thursday snapped up another 3,41,186 shares, worth about $110 million, of the biggest U.S. cryptocurre...

Via Benzinga

Cathie Wood Trims Tesla Stake And Loads Up Heavily On Coinbase ↗

April 14, 2021

Cathie Wood-led Ark Investment Management on Wednesday bought 749,205 shares of Coinbase Global Inc (NASDAQ:

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.